Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Current Leases (2021 - 2025)

BioAtla (BCAB) has disclosed Current Leases for 5 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • For Q4 2025, Current Leases rose 70.69% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, up 70.69%, while the annual FY2025 figure was $1.4 million, 70.69% up from the prior year.
  • Current Leases hit $1.4 million in Q4 2025 for BioAtla, up from $1.2 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.7 million in Q2 2024 and bottomed at $554000.0 in Q1 2025.
  • Average Current Leases over 5 years is $1.3 million, with a median of $1.5 million recorded in 2022.
  • On a YoY basis, Current Leases climbed as much as 70.69% in 2025 and fell as far as 63.29% in 2025.
  • BioAtla's Current Leases stood at $1.4 million in 2021, then increased by 9.5% to $1.5 million in 2022, then increased by 6.77% to $1.6 million in 2023, then crashed by 48.52% to $836000.0 in 2024, then skyrocketed by 70.69% to $1.4 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $1.4 million, $1.2 million, and $805000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.